BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/10/2021 1:44:24 AM | Browse: 478 | Download: 1795
 |
Received |
|
2021-06-06 17:10 |
|
Peer-Review Started |
|
2021-06-06 17:13 |
|
First Decision by Editorial Office Director |
|
2021-06-25 09:52 |
|
Return for Revision |
|
2021-06-25 09:52 |
|
Revised |
|
2021-07-09 01:54 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-09-13 02:15 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-09-16 22:35 |
|
Articles in Press |
|
2021-09-16 22:35 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-10-29 08:32 |
|
Publish the Manuscript Online |
|
2021-11-10 01:44 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Case Report |
| Article Title |
Next-generation sequencing technology for diagnosis and efficacy evaluation of a patient with visceral leishmaniasis: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zhou-Ning Lin, Yong-Cheng Sun, Jia-Ping Wang, Yan-Li Lai and Li-Xia Sheng |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Nature Science Foundation of China |
81401321 |
| Basic Public Welfare Research Project of Zhejiang Province |
LGF19H080002 |
| Science Research Project of Medicine and Hygiene of Zhejiang Province |
2018PY052 |
| Public Welfare Science and Technology Project of Ningbo |
2019C50068 |
|
| Corresponding Author |
Li-Xia Sheng, PhD, Chief Doctor, Department of Hematology, Ningbo First Hospital, No. 59, Liuting Street, Haishu District, Ningbo 315000, Zhejiang Province, China. slx800408@163.com |
| Key Words |
Visceral leishmaniasis; Kala-azar; Next-generation sequencing; Hemophagocytic lymphohistiocytosis; Diagnosis; Case report |
| Core Tip |
Visceral leishmaniasis (VL) is an easily overlooked parasitic disease because of its low incidence and atypical clinical manifestations. Here, we report a case of imported VL. Initially, no Leishmania was found in the bone marrow or by spleen biopsy. Leishmania was finally confirmed by metagenomic next-generation sequencing (mNGS) analysis of peripheral blood. Finally, after treatment with amphotericin B, the patient recovered well, and various indicators gradually returned to normal during the follow-up period. As a rapid and accurate detection method, mNGS can be used as an alternative method to diagnose and evaluate suspicious cases. |
| Publish Date |
2021-11-10 01:44 |
| Citation |
Lin ZN, Sun YC, Wang JP, Lai YL, Sheng LX. Next-generation sequencing technology for diagnosis and efficacy evaluation of a patient with visceral leishmaniasis: A case report. World J Clin Cases 2021; 9(32): 9903-9910 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i32/9903.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i32.9903 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
